Vericel Corporation (VCEL) is a Healthcare company in the Biotechnology industry. It has a market capitalization of $2.06B, a trailing price-to-earnings ratio of 85.6 and a free-cash-flow yield of 1.2%. Over the most recent reported fiscal year, revenue grew 16.4%.